No profile data available.
Revolution Medicines, Inc. (RVMD) is a healthcare company in the additional cancer treatment drugs industry, based in Redwood City, United States, with about 883 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$1.13 billion. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $40.67 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
Revolution Medicines reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$40.67 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Merck & Co., Inc. (MRK), Bristol-Myers Squibb Company (BMY), Exelixis, Inc. (EXEL), Summit Therapeutics Inc. (SMMT).